DNMT3A and acute myeloid leukemia: In the present study, we analyzed the HLA distribution in 1,689 AML patients, with 477 AML patients positive for NPM1mutA/D, to validate these findings and, to our knowledge, for the first time, the HLA distribution of AML patients positive for DNMT3A R882H or R882C.